[Inhibitor of carbohydrate metabolism (inhibitor of gluconeogenesis, disaccharidase inhibitor)].
Shishido
T
T
Third Department of Internal Medicine, Yokohama City University School of Medicine.
Inoue
S
S
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives; D015097:3-Mercaptopropionic Acid / Q000494:pharmacology; D020909:Acarbose; D000818:Animals; D050260:Carbohydrate Metabolism; D003511:Cyclohexanols / Q000494:pharmacology; D003523:Cycloserine / Q000494:pharmacology; D004186:Disaccharidases / Q000037:antagonists & inhibitors*; D005943:Gluconeogenesis / Q000187:drug effects*; D005944:Glucosamine / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology; D050112:Imino Pyranoses; D008099:Liver / Q000378:metabolism; D009829:Oleic Acids / Q000494:pharmacology; D014312:Trisaccharides / Q000494:pharmacology
D003511:Cyclohexanols; D006834:Hydrazines; D050112:Imino Pyranoses; D009829:Oleic Acids; D014312:Trisaccharides; C045621:miglitol; C054577:AO 128; D017485:1-Deoxynojirimycin; D003523:Cycloserine; D015097:3-Mercaptopropionic Acid; D004186:Disaccharidases; D005944:Glucosamine; D020909:Acarbose